药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Canagliflozin.
Sulfacytine
Nialamide
Nialamide may increase the orthostatic hypotensive activities of Canagliflozin.
Sulfacytine
Iproniazid
Iproniazid may increase the orthostatic hypotensive activities of Canagliflozin.
Sulfacytine
Clorgiline
Clorgiline may increase the orthostatic hypotensive activities of Canagliflozin.
Sulfacytine
Pargyline
Pargyline may increase the orthostatic hypotensive activities of Canagliflozin.
Sulfacytine
Rasagiline
Rasagiline may increase the orthostatic hypotensive activities of Canagliflozin.
Sulfacytine
Lumacaftor
The serum concentration of Canagliflozin can be decreased when it is combined with Lumacaftor.
Sulfacytine
Dimetacrine
Dimetacrine may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Tianeptine
Tianeptine may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Imipramine oxide
Imipramine oxide may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Iprindole
Iprindole may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Lofepramine
Lofepramine may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Melitracen
Melitracen may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Quinupramine
Quinupramine may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Dibenzepin
Dibenzepin may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Amitriptylinoxide
Amitriptylinoxide may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Opipramol
Opipramol may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Oxaprotiline
Oxaprotiline may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Dosulepin
Dosulepin may decrease the hypoglycemic activities of Canagliflozin.
Sulfacytine
Butriptyline
Butriptyline may decrease the hypoglycemic activities of Canagliflozin.